News

A new study has highlighted the benefits of whole genome sequencing of classic Hodgkin lymphoma over exome sequencing.

A 53-year-old male patient in Düsseldorf is the third person to achieve long-term human immunodeficiency virus type 1 (HIV-1) remission after receiving a stem cell therapy. The case study is published in Nature.

According to research, the loss of a single copy of CDKNA/B genes can significantly accelerate the recurrence of aggressive meningiomas.

A new study has identified three substances that can fight tumour growth and reduce liver metastases.

A specific subset of immune cells – CD5+ dendritic cells – might make the difference between a patient responding to immunotherapy, or not.

Researchers have engineered antibody fragments that work by forming a covalent bond with the target upon irradiation with UV light of a specific wavelength.

Researchers may have found success targeting STAT5, a protein that has been consigned to the “undruggable” category, with a new approach.

Researchers have used artificial intelligence (AI) to track cell movement over time and space, in a method that could be helpful for the development of more effective cancer therapies.

The blood pressure drug losartan has been shown to reduce tumor invasion and immunosuppression in pancreatic cancer patients undergoing combination therapy treatment.

According to research, breast cancer risk estimates for individual women differ depending on which risk assessment model is used, and women are likely receiving vastly different recommendations depending on the model used.